Abstract
Lassa fever (Lf) is a viral haemorrhagic disease endemic to West Africa and is caused by the Lassa mammarenavirus. The rodent Mastomys natalensis serves as the primary reservoir and its ecology and behaviour have been linked to the distinct spatial and temporal patterns in the incidence of Lf. Nigeria has experienced an unprecedented epidemic that lasted from January until April of 2018, which has been followed by subsequent epidemics of Lf in the same period every year since. While previous research has modelled the case seasonality within Nigeria, this did not capture the seasonal variation in the reproduction of the zoonotic reservoir and its effect on case numbers. To this end, we introduce an approximate Bayesian computation scheme to fit our model to the case data from 2018–2020 supplied by the NCDC. In this study we used a periodically forced seasonal nonautonomous system of ordinary differential equations as a vector model to demonstrate that the population dynamics of the rodent reservoir may be responsible for the spikes in the number of observed cases in humans. The results show that in December through to March, spillover from the zoonotic reservoir drastically increases and spreads the virus to the people of Nigeria. Therefore to effectively combat Lf, attention and efforts should be concentrated during this period.
Author summary Lassa fever is a viral disease prevalent in West Africa, with Mastomys natalensis serving as the primary reservoir. In Nigeria, annual outbreaks occur from December to March. Using a novel model and data from 2018-2020, we demonstrate that the population dynamics of the reservoir contribute to spikes in human cases. Specifically, spillover transmission increases drastically during this period, highlighting the need for concentrated efforts and interventions. Understanding the seasonal dynamics of the reservoir is crucial for effective Lassa fever control and prevention strategies in Nigeria.
Competing Interest Statement
We have no competing interests that we are aware of.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No clinical trial conducted in this manuscript
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
NCDC situation reports for lassa fever are readily available at https://reliefweb.int/country/nga. Codebase and specific time-series data used can be found in the public github repository at https://github.com/JimmyMckendrick1/LassaFever_SeasonalityNigeria
https://reliefweb.int/country/nga
https://github.com/JimmyMckendrick1/LassaFever_SeasonalityNigeria